PJP

PJP
About Invesco Pharmaceuticals ETF
The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum,...
About Invesco Pharmaceuticals ETF
The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum,...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
LLY | Eli Lilly and Company | 5.41% | 16.50K | $18.57M |
ABBV | AbbVie Inc. | 5.39% | 82.44K | $18.54M |
ABT | Abbott Laboratories | 5.35% | 202.71K | $18.40M |
AMGN | Amgen Inc. | 5.29% | 52.30K | $18.07M |
PFE | Pfizer Inc. | 5.16% | 679.63K | $17.46M |
MRK | Merck & Co., Inc. | 5.13% | 146.75K | $17.65M |
JNJ | Johnson & Johnson | 5.09% | 76.33K | $17.42M |
GILD | Gilead Sciences, Inc. | 4.94% | 131.37K | $16.97M |
CORT | Corcept Therapeutics Incorporated | 3.57% | 163.72K | $12.26M |
HRMY | Harmony Biosciences Holdings, Inc. | 3.15% | 328.43K | $10.82M |
OCUL | Ocular Therapeutix, Inc. | 3.05% | 1.19M | $10.49M |
AMRX | Amneal Pharmaceuticals, Inc. | 3.04% | 772.66K | $10.45M |
TVTX | Travere Therapeutics, Inc. | 3.00% | 223.13K | $10.30M |
LQDA | Liquidia Corporation | 2.99% | 164.44K | $10.28M |
BIIB | Biogen Inc. | 2.92% | 51.18K | $10.05M |
JAZZ | Jazz Pharmaceuticals plc | 2.91% | 41.63K | $9.99M |
PRGO | Perrigo Company plc | 2.90% | 915.03K | $9.76M |
LGND | Ligand Pharmaceuticals Incorporated | 2.88% | 41.99K | $9.91M |
REGN | Regeneron Pharmaceuticals, Inc. | 2.85% | 15.57K | $9.79M |
TARS | Tarsus Pharmaceuticals, Inc. | 2.84% | 161.58K | $9.75M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
LLY
Eli Lilly and Company
ABBV
AbbVie Inc.
ABT
Abbott Laboratories
AMGN
Amgen Inc.
PFE
Pfizer Inc.
MRK
Merck & Co., Inc.
JNJ
Johnson & Johnson
GILD
Gilead Sciences, Inc.
CORT
Corcept Therapeutics Incorporated
HRMY
Harmony Biosciences Holdings, Inc.
OCUL
Ocular Therapeutix, Inc.
AMRX
Amneal Pharmaceuticals, Inc.
TVTX
Travere Therapeutics, Inc.
LQDA
Liquidia Corporation
BIIB
Biogen Inc.
JAZZ
Jazz Pharmaceuticals plc
PRGO
Perrigo Company plc
LGND
Ligand Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
TARS
Tarsus Pharmaceuticals, Inc.
